$20,000 of BOSTON SCIENTIFIC CORPORATION lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Medical Supply Chain program reforms HR 6549, VA Contracting and Procurement Act"
You can find more data on corporate lobbying on Quiver Quantitative.
BSX Congressional Stock Trading
Members of Congress have traded $BSX stock 9 times in the past 6 months. Of those trades, 3 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $BSX stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 11/18, 10/17 and 1 sale worth up to $15,000 on 07/31.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 4 times. They made 1 purchase worth up to $15,000 on 10/30 and 3 sales worth up to $45,000 on 10/31, 10/30, 08/04.
- REPRESENTATIVE KEVIN HERN sold up to $50,000 on 10/28.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
BSX Insider Trading Activity
BSX insiders have traded $BSX stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $BSX stock by insiders over the last 6 months:
- JOSEPH MICHAEL FITZGERALD (EVP & Group Pres, Cardiology) has made 0 purchases and 8 sales selling 200,000 shares for an estimated $20,399,750.
- ARTHUR C BUTCHER (EVP& Grp Pres, MedSurg & APAC) has made 0 purchases and 2 sales selling 34,626 shares for an estimated $3,569,708.
- ELLEN M ZANE has made 0 purchases and 3 sales selling 25,782 shares for an estimated $2,573,877.
- EDWARD J LUDWIG sold 4,000 shares for an estimated $424,120
- YOSHIAKI FUJIMORI sold 2,901 shares for an estimated $310,377
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BSX Hedge Fund Activity
We have seen 922 institutional investors add shares of BSX stock to their portfolio, and 675 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 17,996,024 shares (-55.1%) from their portfolio in Q3 2025, for an estimated $1,756,951,823
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 9,206,700 shares (+72.2%) to their portfolio in Q3 2025, for an estimated $898,850,121
- FMR LLC removed 8,832,876 shares (-8.2%) from their portfolio in Q3 2025, for an estimated $862,353,683
- PARNASSUS INVESTMENTS, LLC added 6,868,459 shares (+42978.9%) to their portfolio in Q3 2025, for an estimated $670,567,652
- POLEN CAPITAL MANAGEMENT LLC added 5,598,286 shares (+inf%) to their portfolio in Q3 2025, for an estimated $546,560,662
- VOYA INVESTMENT MANAGEMENT LLC removed 4,362,310 shares (-49.9%) from their portfolio in Q3 2025, for an estimated $425,892,325
- MILLENNIUM MANAGEMENT LLC added 3,888,802 shares (+83.9%) to their portfolio in Q3 2025, for an estimated $379,663,739
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BSX Analyst Ratings
Wall Street analysts have issued reports on $BSX in the last several months. We have seen 13 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 12/17/2025
- BTIG issued a "Buy" rating on 11/21/2025
- Truist Securities issued a "Buy" rating on 10/23/2025
- UBS issued a "Buy" rating on 10/23/2025
- Needham issued a "Buy" rating on 10/17/2025
- Evercore ISI Group issued a "Outperform" rating on 10/07/2025
- Leerink Partners issued a "Outperform" rating on 10/01/2025
To track analyst ratings and price targets for BSX, check out Quiver Quantitative's $BSX forecast page.
BSX Price Targets
Multiple analysts have issued price targets for $BSX recently. We have seen 14 analysts offer price targets for $BSX in the last 6 months, with a median target of $128.0.
Here are some recent targets:
- Richard Newitter from Truist Securities set a target price of $120.0 on 12/18/2025
- William Plovanic from Canaccord Genuity set a target price of $131.0 on 12/17/2025
- Shagun Singh from RBC Capital set a target price of $130.0 on 12/17/2025
- Marie Thibault from BTIG set a target price of $132.0 on 11/21/2025
- Danielle Antalffy from UBS set a target price of $140.0 on 10/23/2025
- Larry Biegelsen from Wells Fargo set a target price of $125.0 on 10/23/2025
- Patrick Wood from Morgan Stanley set a target price of $130.0 on 10/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
